PTGS2 and prostate cancer: BPH tissues and prostate cancer cells express toll-like receptor 4 (TLR4) and are characterized by increased immune-mediated inflammatory processes and secretion of cytokines, such as IL-1β, IL-6, IL-8, TNF-α, and COX-2 [9,44,45].